Publications
- Development of submicromolar 17 beta-HSD10 inhibitors and their in vitro and in vivo evaluation2023 | First Faculty of Medicine
- Tacrine First-Phase Biotransformation and Associated Hepatotoxicity: A Possible Way to Avoid Quinone Methide Formation2023 | Faculty of Pharmacy in Hradec Králové
- Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonists2021 | Faculty of Pharmacy in Hradec Králové, Faculty of Science
- 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease2021 | Publication without faculty affiliation
- Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease2021 | Publication without faculty affiliation
- Aromatic Esters of the Crinane Amaryllidaceae Alkaloid Ambelline as Selective Inhibitors of Butyrylcholinesterase2020 | Faculty of Pharmacy in Hradec Králové
- Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profile2020 | Publication without faculty affiliation
- Novel sustainable-by-design HDAC inhibitors for the treatment of Alzheimer's disease2019 | Publication without faculty affiliation
- Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease2019 | Publication without faculty affiliation
- New dual small molecules for Alzheimer's disease therapy combining histamine H-3 receptor (H3R) antagonism and calcium channels blockade with additional Cholinesterase inhibition2019 | Publication without faculty affiliation
Loading network view...